Association of Adherence to Surfactant Best Practice Uses With Clinical Outcomes Among Neonates in Sweden
Author(s) -
Pontus Challis,
Per Nydert,
Stellan Håkansson,
Mikael Norman
Publication year - 2021
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2021.7269
Subject(s) - medicine , gestational age , respiratory distress , surfactant therapy , pediatrics , retinopathy of prematurity , mechanical ventilation , population , apgar score , bronchopulmonary dysplasia , cohort , birth weight , pregnancy , anesthesia , genetics , environmental health , biology
Key Points Question What strategies for surfactant treatment of newborn infants are used, and how are these strategies associated with outcomes? Findings In this cohort study of 5209 infants who received 7980 surfactant administrations, late surfactant treatment (>2 hours after birth) was provided for 39% of very preterm infants and associated with higher neonatal morbidity. Off-label use occurred in 19% of infants without any association to outcome, and treatment omissions were associated with lower survival. Meaning In this study, adherence to best practices for surfactant use in newborn infants varied, with important clinical implications for neonatal outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom